@thehollyresearch: Tesamorelin's strongest evidence isn't for general weight loss. It's for altering visceral abdominal fat in people living with HIV. 🧬🔥 Research has also found reductions in liver fat in people with HIV and fatty liver disease, making the GHRH/GH pathway an interesting area of metabolic research. But evidence from a specific clinical population shouldn't automatically be applied to everyone. #tesa #visceralfat #liverfat #pep #metabolism